新闻Aribiousa attended event 2025 BIO International Convention on Jun 20th '25.AriBio announced on the 12th that it will participate in the 2025 BIO International Convention (hereafter BIO USA), which will be held in Boston, USA, for four days from June 16 (local time) to 19.
新闻Aribiousa is developing therapeutics for kidney on May 12th '25.AriBio announced today that it has entered into a partnership with U.S.-based biotech company Restari to jointly develop new therapeutics for kidney and liver diseases, leveraging AriBio's phosphodiesterase 5 (PDE5) inhibitor technology.
新闻Aribiousa partners with Kentuckyctl.SEONGNAM-SI, South Korea & LOUISVILLE, Ky.-(BUSINESS WIRE)- AriBio Co., Ltd. (AriBio) announces the expansion of testing for Alzheimer's disease by entering into a strategic collaboration with Kentucky Clinical Trial Laboratory (KCTL) for the testing of cerebral spinal fluid (CSF) to accurately and efficiently aid in the diagnosis of Alzheimer's disease using the Lumipulse(R) system from FujireBio.
